Corticosteroid therapy for nephrotic syndrome in children

Updated review (48 studies, n=3941) states there are now four well designed RCTs (n=823) which have clearly demonstrated that there is no benefit of prolonging prednisone therapy beyond two to three months in the first episode of steroid‐sensitive nephrotic syndrome.

Source:

Cochrane Database of Systematic Reviews